Gábor Tigyi

14PUBLICATIONS
31CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Fluid-structure interaction and aeroacousticsProsthodonticsInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 25, 2025
Structure-Based Discovery of MolPort-137: A Novel Autotaxin Inhibitor That Improves Paclitaxel Efficacy.

Prateek Rai, Christopher J Clark, Vandana Kardam

|Sep 28, 2024
Novel Autotaxin Inhibitor ATX-1d Significantly Enhances Potency of Paclitaxel-An In Silico and In Vitro Study.

Prateek Rai, Christopher J Clark, Carl B Womack

|Jul 13, 2024
LPA-Induced Thromboxane A2-Mediated Vasoconstriction Is Limited to Poly-Unsaturated Molecular Species in Mouse Aortas.

Krisztina Vén, Balázs Besztercei, Anna Janovicz

|Jul 12, 2024
Establishing Three-Dimensional Explant Culture of Human Dental Pulp Tissue.

Eun Jin Seo, Soyoung Park, Eungyung Lee

|Oct 14, 2023
Autotaxin-lysophosphatidic acid receptor 5 axis evokes endothelial dysfunction via reactive oxygen species signaling.

Anna Janovicz, Aliz Majer, Mónika Kosztelnik

|Jun 26, 2023
E2F7 drives autotaxin/Enpp2 transcription via chromosome looping: Repression by p53 in murine but not in human carcinomas.

Kuan-Hung Lin, Sue Chin Lee, Mélanie A Dacheux

Pageof 3

Frequent Collaborators

5 joint publications

Zoltán Benyó

3 joint publications

Éva Ruisanchez

3 joint publications

Souvik Banerjee

2 joint publications

Anna Janovicz